Angelica Benavides-Serrato

Statistics

Publications

Citations

566

H-Index

Active since

2011

Affiliations

University of California, Los Angeles(Current)

VA Greater Los Angeles Healthcare System

UCLA Jonsson Comprehensive Cancer Center

University of Colorado Cancer Center

University of Colorado Denver

Angelica Benavides-Serrato is an author at University of California, Los Angeles specializing in oncology, molecular oncology, and signal transduction.

Publications per year

2011–2023

Publications

Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness

Nicholas Artinian, Cheri Cloninger, Brent Holmes et al. · Journal of Biological Chemistry · 2015 · 92 citations · Full text

Medicine, Cell Biology, Oncology +17

Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma

Angelica Benavides-Serrato, Ji‐Hye Lee, Brent Holmes et al. · PLoS ONE · 2017 · 80 citations · Full text

Medicine, Oncology, Pharmacology +16

The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma

Brent Holmes, Angelica Benavides-Serrato, Jacquelyn T. Saunders et al. · Journal of Neuro-Oncology · 2019 · 57 citations · Full text

Medicine, Molecular Biology, Oncology +10

Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma

Brent Holmes, Jihye Lee, Kenna A. Landon et al. · Journal of Biological Chemistry · 2016 · 50 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice

Tariq Bashir, Cheri Cloninger, Nicholas Artinian et al. · PLoS ONE · 2012 · 48 citations · Full text

Medicine, Neuroscience, Oncology +9

1–5 of 13